A new medication containing L-glutamic acid get FDA approval for treating the relapse in MS

Published Date: Nov 2015

Teva Pharmaceutical Industries Ltd, a global pharmaceutical company major has recently announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved injection of COPAXONE® as for treating relapses in multiple sclerosis (MS).

The once per day 20 mg injection of COPAXONE was approved to be used as prophylaxis. The active ingredient of COPAXONE is acetate salts of synthetic polypeptides, which contains amino acids such as L-glutamic acid, L-alanine, L-lysine and L-tyrosine. All are naturally occurring substances. Glatiramer acetate has been approved by the Food and Drug Administration (FDA) in the US for being helpful in the reduction of relapse frequency for the disease multiple sclerosis.

L-glutamine helps in the production of the natural anti-oxidant glutathione, which has a crucial role in preventing cell damage since it is a powerful neuro-transmiter for central nervous system.

The approval of COPAXONE by the ministry followed favorable efficacy and results of a 52-week, open-label study. The study was conducted in Japan by the manufacturer in patients affected with relapsing-remitting MS.

There are many clinical studies done which has reinforced the efficacy of glutamine as a crucial nutrient for the prevention of various diseases such as cancer, Crohn’s disease and other tumor. The human body can produce L-glutamine itself, using L-glutamic acid as a neurotransmitter, but the deficiency can lead to the development of tumors. Many L-glutamic acid supplements are available in the nutritional market which can be taken after proper clinical recommendation. There are many reports in the market which tracks the demand of the compound L-glutamic acid along with offering industry insights into the current and future market trends. A recent report added by Prof Research Reports titled “Global and Chinese L-Glutamic Acid (CAS 56-86-0) Industry, 2009-2019 Market Research Report” offers a detailed insights into the changing market dynamics in terms of key drivers and restraints, market profile of key market players along with detailed segmentation and forecast.

Share This News
facebooktwitterlinkedingoogleplusstumbleuponreddit
24/7 Customer Support
check Have questions?
Direct
+1-971-202-1575
Toll Free
+1(855)711-1555 or2
email help@profresearchreports.com
Market Research

Prof Research Report is a high end market research & consulting firm that offers current and future market intelligence across 30 industrial verticals such as energy, new materials, transportation, daily consumer goods, chemicals, etc through is quality database. Prof Research Report has successfully utilized technology to manage complex and massive market related database, which offers research reports of high analytical value. Prof Research Report’s aim is to help our clients in achieving sustainable growth by providing insightful and qualitative research reports. Our research reports help our clients to achieve the competitive edge in the market.

Vision:

To be a world class provider of market research reports.

Mission:

To create a database of reliable and accurately analyzed report and be the decision making support for our clients.

CONTACT 5320 SW MACADAM AVENUE, SUITE 100, PORTLAND, OR 97239, UNITED STATES. © 2016. ALL RIGHTS RESERVED PROF RESEARCH REPORTS.